Publication | Open Access

Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model

Cancer ImmunosurveillanceT-regulatory CellMurine ModelImmunologyTumor ImmunityTherapeutic VaccineProphylactic Dna VaccineAutoimmunityT Cell ImmunityAnti-melanoma Immune ResponsesCellular Immune ResponseImmunotherapyMedicineCell BiologyTumor Microenvironment